Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
07/2012
07/24/2012US8226949 Stabilizing alkylglycoside compositions and methods thereof
07/24/2012CA2536482C Penetrating pharmaceutical foam
07/24/2012CA2535724C Compositions containing topical active agents and pentylene glycol
07/24/2012CA2490116C Acidic insulin preparations with improved stability
07/24/2012CA2488121C Micelle assemblies
07/24/2012CA2477053C Composition for easing human childbirth
07/24/2012CA2473700C Method for stabilizing reduced coenzyme q10 and composition therefor
07/24/2012CA2458146C Use of milk serum apoproteins in the prophylaxis or treatment of microbial or viral infection
07/24/2012CA2438334C Ocular tear growth factor-like protein
07/24/2012CA2410887C Compounds for targeting endothelial cells, compositions containing the same and methods for their use
07/24/2012CA2256327C Polysaccharide sponges for cell culture and transplantation
07/19/2012WO2012097264A2 Pharmaceutical compositions for topical delivery of photosensitizers and uses thereof
07/19/2012WO2012097255A2 Therapeutic effect of heat shock proteins in preventing amylin aggregation in type 2 diabetes mellitus
07/19/2012WO2012097223A2 Oligosaccharide conjugates for targeting bacteria and uses related thereto
07/19/2012WO2012097222A1 High drug load tablet formulation of brivanib alaninate
07/19/2012WO2012097078A2 Viscosupplementary materials
07/19/2012WO2012097049A2 Dna repair enzyme inhibitor nanoparticles and uses thereof
07/19/2012WO2012096926A2 Method for delivering agents into cells using bacterial toxins
07/19/2012WO2012096697A1 Methods and compositions for treating conditions related to lack of blood supply, shock and neuronal injuries
07/19/2012WO2012096399A1 Particle composition and pharmaceutical composition using particle composition
07/19/2012WO2012096276A1 Percutaneous absorption promoter and external skin preparation
07/19/2012WO2012095774A1 Self assembled nanostructured saliva substitutes
07/19/2012WO2012095543A1 Nanocapsules with a polymer shell
07/19/2012WO2012095527A1 Methods and reagents for efficient and targeted delivery of therapeutic molecules to cxcr4 cells
07/19/2012WO2012095439A1 Use of liquid medium exchange by cross flow filtration in the preparation of drug suspensions
07/19/2012WO2012095438A1 Particles and suspensions of cephalosporin antibiotics
07/19/2012WO2012075326A3 Treatment of inflammatory diseases by targeting the adaptor protein ciks
07/19/2012WO2012075319A3 Pharmaceutical cream compositions comprising oxymetazoline
07/19/2012WO2012068998A3 Triamcinolone acetonide ophthalmic preparation and preparation method thereof
07/19/2012WO2012064087A3 Pharmaceutical composition including polymer microsphere containing anastrozole as active ingredient
07/19/2012WO2012063498A3 Novel exemestane solid dispersion
07/19/2012WO2012056476A4 A detoxifier herbal formulation
07/19/2012WO2012050923A3 Engineered polypeptides having enhanced duration of action
07/19/2012WO2012050810A3 Shape-controlled magnetic nanoparticles as t1 contrast agents for magnetic resonance imaging
07/19/2012WO2012021735A3 Pharmaceutical products from fungal strains
07/19/2012WO2012015687A3 Drug-ligand conjugates, synthesis thereof, and intermediates thereto
07/19/2012WO2012012305A3 Combination therapy using a ruthenium complex
07/19/2012WO2010147484A8 Compositions and methods for treatment of multiple sclerosis
07/19/2012US20120184627 Pharmaceutical composition
07/19/2012US20120184615 Stabilised prostaglandin composition
07/19/2012US20120184551 Combination of brimonidine and timolol for topical ophthalmic use
07/19/2012US20120184502 Optimised formulation of tobramycin for aerosolization
07/19/2012US20120184011 Emulsion Compositions
07/19/2012US20120183629 Low viscosity liquid polymeric delivery system
07/19/2012US20120183612 Matrix for sustained, invariant and independent release of active compounds
07/19/2012US20120183602 Lipid formulation
07/19/2012US20120183595 Transdermal Pharmaceutical Delivery Composition
07/19/2012US20120183593 Hydrogels used to deliver medicaments to the eye for the treatment of posterior segment diseases
07/19/2012US20120183585 Gel based wound dressing and a method of synthesizing the same
07/19/2012US20120183584 Method for preparing a stable oil-in-water emulsion
07/19/2012US20120183583 Medical Device With Intrapore Films
07/19/2012US20120183582 Oral Delivery of Peptides
07/19/2012US20120183578 Polyethylene glycol-based dendrons
07/19/2012US20120183567 Process for producing water-soluble hyaluronic acid modification
07/19/2012US20120183550 Therapeutic Using a Bispecific Antibody
07/19/2012US20120183544 Diagnosis and treatment of neuroectodermal tumors
07/19/2012US20120183531 Methods for Inhibiting Yellow Color Formation in a Composition
07/19/2012US20120183530 Stabilized immune modulatory rna (simra) compounds
07/19/2012US20120183500 Articles and methods including stable thermally-responsive polymers
07/19/2012CA2824800A1 Oligosaccharide conjugates for targeting bacteria and uses related thereto
07/19/2012CA2824768A1 Pharmaceutical compositions for topical delivery of photosensitizers and uses thereof
07/19/2012CA2824154A1 Method for delivering agents into cells using bacterial toxins
07/19/2012CA2824143A1 Aldehyde-tagged immunoglobulin polypeptides and method of use thereof
07/19/2012CA2823972A1 Use of liquid medium exchange by cross flow filtration in the preparation of drug suspensions
07/18/2012EP2476753A1 Construct coated with virus coat-constituting protein and method for producing same
07/18/2012EP2476726A1 Processing of chitosan and chitosan derivatives
07/18/2012EP2476706A2 Anti-MN antibodies and methods of using same
07/18/2012EP2476461A2 Formulations For Cancer Treatment
07/18/2012EP2476441A1 Methods and reagents for efficient and targeted delivery of therapeutic molecules to CXCR4 cells
07/18/2012EP2476440A1 Therapeutic compositions for the treatment of hpv-induced diseases
07/18/2012EP2476439A1 Aqueous composition for enteric hard capsules, production method for enteric hard capsules and enteric hard capsules
07/18/2012EP2476430A1 Pegylated insulin lispro compounds
07/18/2012EP2476420A1 Pharmaceutical composition having antimicrobial and fast-healing activity for external administration, process for preparing same
07/18/2012EP2476419A1 Pharmaceutical composition having antimicrobial and anti-inflammatory activity for parenteral administration, process for preparing same
07/18/2012EP2476414A1 Transdermally absorbable preparation
07/18/2012EP2476413A1 Liquid composition to be filled in soft capsules
07/18/2012EP2475695A1 Implantable bio-resorbable polymer
07/18/2012EP2475398A1 Improved pseudomonas exotoxin a with reduced immunogenicity
07/18/2012EP2475397A1 Use of interleukin-1 beta mutein conjugates in the treatment of diabetes
07/18/2012EP2475396A2 Engineered microparticles for macromolecule delivery
07/18/2012EP2475395A2 High strength seamless alginate capsules
07/18/2012EP2475394A2 Seamless alginate capsules
07/18/2012EP2475376A2 Formulations for lysosomal enzymes
07/18/2012EP2475358A1 Anionic-core composition for delivery of therapeutic agents, and methods of making and using the same
07/18/2012EP2475357A1 Oral suspension formulations of esclicarbazepine acetate
07/18/2012EP2475351A1 Novel powdered polymer, preparation method thereof and use of same as a thickener
07/18/2012EP2070917B1 Flavor improving agent and food or drink containing the same
07/18/2012EP1931346B1 Trazodone composition for once a day administration
07/18/2012EP1669065B1 Drug containing (2r)-2-propyloctanoic acid as the active ingredient
07/18/2012CN1794983B Aqueous olanexidine solution, method of preparing the same, and disinfectant
07/18/2012CN1723041B Stable immunogenic product comprising antigenic heterocomplexes
07/18/2012CN1473035B Compositions containing substained-release fine grains for tablets quickly disintegrable in oral cavity and process for producing same
07/18/2012CN102597030A Implantable bio-resorbable polymer
07/18/2012CN102596993A Multimeric peptide conjugates and uses thereof
07/18/2012CN102596982A Agent for inhibiting thickening of peritoneal membrane
07/18/2012CN102596877A Method for preparing a composition comprising a compound based on vanillin and ethyl vanillin, resulting composition and uses thereof
07/18/2012CN102596254A Conjugation of staphylococcus aureus type 5 and type 8 capsular polysaccharides
07/18/2012CN102596253A Mucoadhesive polymers having vitamin B partialstructures
07/18/2012CN102596252A Gastric retentive pharmaceutical compositions for immediate and extended release of acetaminophen
07/18/2012CN102596251A High strength seamless alginate capsules
1 ... 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 ... 1712